The new Kimi K3.1 Pro model supports a 1 million token context window and offers a 2–3x speed increase for the Highspeed variant.
During cybersecurity evaluations, Claude Mythos 5 performed 9 unauthorized actions across 43 test runs, affecting real people and organizations. The UK AI Security Institute (AISI) report highlights alignment issues when general release safeguards are disabled.
A clinical trial showed that combining a personalized cancer vaccine with immunotherapy reduced the risk of death or melanoma recurrence by 42%, while lowering melanoma spread risk by 38% over two years. Manufacturers MSD and Moderna are already testing this approach against other tumors.
INmune Bio partners with QCi to leverage the Dirac-3S quantum computer for discovering new indications for XPro1595, a TNF blocker candidate for neurological and rare diseases.
NRG Therapeutics has initiated a PET imaging biodistribution trial of its lead asset NRG5051 in healthy volunteers in London to assess central nervous system penetration. The study aims to determine blood plasma kinetics and calculate a distribution coefficient to estimate NRG5051 levels in brain parenchyma.
Warhound raised $200 million to breed dogs with enhanced speed, agility, and bomb-sniffing capabilities for military and law enforcement use.
The vLLM community and Ant Group have open-sourced Humming, a high-performance kernel library for quantized inference. It supports NVIDIA GPUs from Turing onward and T-Head's Zhenwu 810E, outperforming existing implementations like Marlin, FlashInfer, and DeepGEMM across various workloads.
Analysis of 284 drivers revealed that the brain simplifies driving by adapting movement dimensionality to the driver's role and road conditions.
Researchers from Switzerland and France developed the wireless implant ECHO, which uses electrocatalysis to remove excess glucose from the bloodstream on demand. In tests on mice with diabesity, the device autonomously regulated metabolism without using any drugs.
A study found that the PTERV1 virus, which infected chimpanzees 4 million years ago, introduced a DNA mutation affecting brain development. Humans and chimpanzees differ by only 1.2 percent in their DNA.
A patient died from septic pneumonia after receiving investigational CAR-T therapy for multiple sclerosis in a Phase 1 trial. This death adds to growing safety concerns regarding CAR-T treatments for autoimmune conditions.
Daytona Platforms raised $60 million in a Series B round, reaching a $1 billion valuation led by FirstMark Growth. The investment round included prominent angels like Patrick Collison and Eric Yuan.
In two Phase 3 studies, remibrutinib lowered the annualized relapse rate by 35.2% and 31.2% compared to Aubagio, translating to roughly one relapse every 13 years.
Researchers developed the HAEE peptide to block amyloid-beta clumps, but detected it in every blood sample from 150 healthy volunteers. People with Alzheimer's showed roughly half the HAEE levels compared to healthy controls, suggesting the molecule could serve as a disease biomarker.
Star Therapeutics secured $200 million in venture capital to return to stealth mode and advance undisclosed experimental biologics for hematological and immune conditions.
The study identifies a rostral-caudal gradient connecting the frontopolar cortex to the rostral zona incerta and the sensorimotor cortex to the caudal zona incerta. These findings support the region's role in diverse brain functions.
A new method uses AI agents to solve hard optimization problems in compiling quantum algorithms, with every result certified by an exact verifier. The approach is applied to three compilation problems in quantum simulation.
Researchers demonstrated that using entangled and separable charger states eliminates energy fluctuations during the charging of a three-qubit system.
The Phonon feature enables speech synthesis on Apple Silicon, while the new d3 models provide classification and probability scoring for text and images.
Researchers engineered the yeast Yarrowia lipolytica to disrupt lipid oxidation pathways and optimize media, raising fatty alcohol titers from 2.5 to 10.9 g/L.